Neurocognitive characteristics in children with sluggish cognitive tempo
Chutko LS, Yakovenko EA, Surushkina SY, Shcheglova LV · 2026 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 126(9)
Published 2026-10-20. Indexed 2026-10-21.
Reported findings and study design
After Cortexin treatment, the authors reported improvement in attention, working memory, fatigue symptoms and reading skills in 82% of cases in the sluggish-cognitive-tempo group. EEG changes accompanied the clinical observations. ADHD and healthy children were diagnostic reference groups, not randomized untreated children with the same condition.
Dose, route and schedule
Cortexin 10 mg intramuscularly every other day for ten injections, as reported in the study abstract. This pediatric study regimen is not prescribing guidance.
Protocol source ↗ · Indexed abstract checked
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Treated clinical group | 40 children ages 12–14 | |
| Reported improvement | 82% of cases | Attention, working memory, fatigue and reading assessed after treatment; do not infer an exact responder count from the rounded percentage |
| Reference groups | 30 children with combined ADHD; 30 healthy children | These are diagnostic comparisons, not a placebo-controlled treatment comparison |
Before-and-after treatment observation without a randomized placebo comparison in the affected group. The abstract does not give endpoint-specific effect sizes, a response definition sufficient to reconstruct individual counts, or an adverse-event rate.
Source for the extracted data ↗ · Checked 2026-10-31
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Before-and-after treatment observation without a randomized placebo comparison in the affected group. The abstract does not give endpoint-specific effect sizes, a response definition sufficient to reconstruct individual counts, or an adverse-event rate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Indexed abstract checked
Source access and review scope
Primary publication metadata and indexed abstract checked through Europe PMC on 31 October 2026. No unavailable effect sizes inferred. Publisher page confirms online publication 2026-10-20.
Recorded source-check date: 2026-10-31. This date does not imply a completed systematic review.
Source type: Journal publication
Citation and original source
Original source: Chutko LS, Yakovenko EA, Surushkina SY, Shcheglova LV. Neurocognitive characteristics in children with sluggish cognitive tempo Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 126(9) 2026.
Molekul research summary: https://molekul.io/research/oct31-42899917. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry